Numinus Wellness Inc. (NUMIF) Stock

About Numinus Wellness Inc.

Numinus Wellness Inc. is dedicated to pioneering and delivering psychedelic-assisted psychotherapy, with the overarching goal of reshaping the mental healthcare landscape. The company's operations are segmented into two primary divisions: Salvation Botanicals and Numinus Health. Salvation Botanicals provides comprehensive laboratory services focused on psychedelics, encompassing cultivation, analytical testing, product research and development, and various ancillary supports. Additionally, this division offers both full-suite and bespoke testing for cannabis products. Numinus Health concentrates on promoting healing, connection, and personal growth through a range of supportive therapies and advanced technologies. This division specializes in addressing mental health challenges and substance abuse, delivering services including psychotherapy, counselling, neurofeedback, physiotherapy, and other therapeutic modalities. Furthermore, Numinus Health equips practitioners with vital training, facilities, and operational resources. The company's headquarters are situated in Vancouver, Canada.

Numinus Wellness Inc. is headquartered in CA.

Numinus Wellness Inc. (NUMIF) stock trades at $0.04 with a market capitalization of $12.85M. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.49, reflecting a net loss over the last twelve months, a negative price-to-book of -9.44, reflecting negative shareholders' equity, price-to-sales of 4.83. Over the past 52 weeks the stock has ranged between $0.01 and $0.06, and currently trades 33.3% below its 52-week high.

On profitability, Numinus Wellness Inc. generates a return on equity (ROE) of 833.04% (not meaningful, as shareholders' equity is negative), return on capital employed of -600.00%, an operating margin of -75.23%, a net profit margin of -297.88%.

Official website: www.numinus.com